168 related articles for article (PubMed ID: 32348807)
21. MiR-106b regulates the apoptosis and tumorigenesis of hepatocellular carcinoma via targeting Zinc finger and BTB domain-containing protein 7A (Zbtb7a).
Liang X; Zhao Q; Geng T; Luo S; He Q
J Biochem Mol Toxicol; 2018 Aug; 32(8):e22169. PubMed ID: 29975452
[TBL] [Abstract][Full Text] [Related]
22. Expression of Zinc Finger and BTB Domain-containing 7A in Colorectal Carcinoma.
Joo JW; Kim HS; Do SI; Sung JY
Anticancer Res; 2018 May; 38(5):2787-2792. PubMed ID: 29715100
[TBL] [Abstract][Full Text] [Related]
23. ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity.
Zhang L; Wang Y; Li X; Xia X; Li N; He R; He H; Han C; Zhao W
Neoplasia; 2017 Nov; 19(11):908-918. PubMed ID: 28942243
[TBL] [Abstract][Full Text] [Related]
24. LRF/ZBTB7A conservation accentuates its potential as a therapeutic target for the hematopoietic disorders.
Chondrou V; Markopoulos GS; Patrinos GP; Kouraklis-Symeonidis A; Symeonidis A; Papachatzopoulou A; Sgourou A
Gene; 2020 Nov; 760():145020. PubMed ID: 32755656
[TBL] [Abstract][Full Text] [Related]
25. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
26. ZBTB7A promotes migration, invasion and metastasis of human breast cancer cells through NF-κB-induced epithelial-mesenchymal transition in vitro and in vivo.
Mao A; Chen M; Qin Q; Liang Z; Jiang W; Yang W; Wei C
J Biochem; 2019 Dec; 166(6):485-493. PubMed ID: 31385585
[TBL] [Abstract][Full Text] [Related]
27. ZBTB7A functioned as an oncogene in colorectal cancer.
Wang L; Zhang MX; Zhang MF; Tu ZW
BMC Gastroenterol; 2020 Nov; 20(1):370. PubMed ID: 33167891
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-induced RelA/p65 derepresses SLC16A3 (MCT4) by downregulating ZBTB7A.
Choi SH; Kim MY; Yoon YS; Koh DI; Kim MK; Cho SY; Kim KS; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):771-785. PubMed ID: 31271899
[TBL] [Abstract][Full Text] [Related]
29. POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.
Lee SU; Maeda T
Immunol Rev; 2012 May; 247(1):107-19. PubMed ID: 22500835
[TBL] [Abstract][Full Text] [Related]
30. The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement.
Fedele M; Crescenzi E; Cerchia L
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186807
[TBL] [Abstract][Full Text] [Related]
31. ZBTB7A, a miR-144-3p targeted gene, accelerates bladder cancer progression via downregulating HIC1 expression.
Liu J; Chou Z; Li C; Huang K; Wang X; Li X; Han C; Al-Danakh A; Li X; Song X
Cancer Cell Int; 2022 May; 22(1):179. PubMed ID: 35501800
[TBL] [Abstract][Full Text] [Related]
32. Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection.
Nayak DK; Zhou F; Xu M; Huang J; Tsuji M; Yu J; Hachem R; Gelman AE; Bremner RM; Smith MA; Mohanakumar T
Sci Transl Med; 2017 Jul; 9(398):. PubMed ID: 28701473
[TBL] [Abstract][Full Text] [Related]
33. ZBTB7A links tumor metabolism to myeloid differentiation.
Redondo Monte E; Kerbs P; Greif PA
Exp Hematol; 2020 Jul; 87():20-24.e1. PubMed ID: 32525064
[TBL] [Abstract][Full Text] [Related]
34. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
35. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis of the role of POK transcriptional repressors.
Costoya JA
Brief Funct Genomic Proteomic; 2007 Mar; 6(1):8-18. PubMed ID: 17384421
[TBL] [Abstract][Full Text] [Related]
37. Sequence-specific transcriptional repression by KS1, a multiple-zinc-finger-Krüppel-associated box protein.
Gebelein B; Urrutia R
Mol Cell Biol; 2001 Feb; 21(3):928-39. PubMed ID: 11154279
[TBL] [Abstract][Full Text] [Related]
38. HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A.
Alam H; Li N; Dhar SS; Wu SJ; Lv J; Chen K; Flores ER; Baseler L; Lee MG
Cancer Res; 2018 Jul; 78(14):3834-3848. PubMed ID: 29764865
[TBL] [Abstract][Full Text] [Related]
39. KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A.
Jeon BN; Kim MK; Choi WI; Koh DI; Hong SY; Kim KS; Kim M; Yun CO; Yoon J; Choi KY; Lee KR; Nephew KP; Hur MW
Cancer Res; 2012 Mar; 72(5):1137-48. PubMed ID: 22253232
[TBL] [Abstract][Full Text] [Related]
40. A Zbtb7a proto-oncogene as a novel target for miR-125a.
Hojo N; Tatsumi N; Moriguchi N; Matsumura A; Morimoto S; Nakata J; Fujiki F; Nishida S; Nakajima H; Tsuboi A; Oka Y; Hosen N; Hayashi S; Sugiyama H; Oji Y
Mol Carcinog; 2016 Dec; 55(12):2001-2009. PubMed ID: 26713860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
